<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.08.0">
<page number="1" position="absolute" top="0" left="0" height="842" width="595">
	<fontspec id="0" size="8" family="Times New Roman" color="#000000"/>
	<fontspec id="1" size="10" family="Times New Roman" color="#000000"/>
	<fontspec id="2" size="28" family="ABCDEE+C39T30Lfz" color="#000000"/>
	<fontspec id="3" size="12" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="4" size="10" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="5" size="14" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="6" size="10" family="Times New Roman,Italic" color="#000000"/>
	<fontspec id="7" size="1" family="Times New Roman" color="#000000"/>
	<fontspec id="8" size="14" family="Times New Roman" color="#000000"/>
	<fontspec id="9" size="20" family="Times New Roman" color="#000000"/>
	<fontspec id="10" size="20" family="Times New Roman,Bold" color="#000000"/>
<text top="725" left="57" width="2" height="7" font="0"> </text>
<text top="734" left="57" width="69" height="9" font="1">GE.16-12307(E) </text>
<text top="748" left="57" width="94" height="28" font="2"></text>
<text top="224" left="57" width="121" height="11" font="3"><b>Human Rights Council </b></text>
<text top="238" left="57" width="94" height="9" font="4"><b>Thirty-second session </b></text>
<text top="250" left="57" width="61" height="9" font="1">Agenda item 3 </text>
<text top="279" left="104" width="390" height="13" font="5"><b>Resolution adopted by the Human Rights Council on 1 July 2016 </b></text>
<text top="312" left="113" width="33" height="11" font="3"><b>32/15. </b></text>
<text top="312" left="170" width="311" height="11" font="3"><b>Access to medicines in the context of the right of everyone to </b></text>
<text top="326" left="170" width="309" height="11" font="3"><b>the enjoyment of the highest attainable standard of physical </b></text>
<text top="339" left="170" width="96" height="11" font="3"><b>and mental health </b></text>
<text top="339" left="283" width="3" height="11" font="3"><b> </b></text>
<text top="365" left="113" width="2" height="9" font="1"> </text>
<text top="365" left="142" width="109" height="9" font="6"><i>The Human Rights Council</i></text>
<text top="365" left="251" width="5" height="9" font="1">, </text>
<text top="383" left="142" width="32" height="9" font="6"><i>Guided </i></text>
<text top="383" left="174" width="274" height="9" font="1">by the purposes and principles of the Charter of the United Nations, </text>
<text top="401" left="142" width="48" height="9" font="6"><i>Reaffirming</i></text>
<text top="401" left="190" width="184" height="9" font="1"> the Universal Declaration of Human Rights,  </text>
<text top="419" left="142" width="67" height="9" font="6"><i>Reaffirming also</i></text>
<text top="419" left="209" width="275" height="9" font="1"> that the right of everyone to the enjoyment of the highest attainable </text>
<text top="431" left="113" width="371" height="9" font="1">standard  of  physical  and  mental  health  is  a  human  right  as  reflected  in,  inter  alia,  the </text>
<text top="443" left="113" width="371" height="9" font="1">Universal  Declaration  of  Human  Rights,  the  International  Covenant  on  Economic,  Social </text>
<text top="455" left="113" width="371" height="9" font="1">and  Cultural  Rights  and  the  Convention  on  the  Rights  of  the  Child,  and,  with  respect  to </text>
<text top="467" left="113" width="371" height="9" font="1">non-discrimination,  in  the  International  Convention  on  the  Elimination  of  All  Forms  of </text>
<text top="479" left="113" width="371" height="9" font="1">Racial Discrimination, the  Convention on  the Elimination  of  All  Forms of Discrimination </text>
<text top="491" left="113" width="371" height="9" font="1">against  Women  and  the  Convention  on  the  Rights  of  Persons  with  Disabilities,  and  that </text>
<text top="503" left="113" width="273" height="9" font="1">such a right derives from the inherent dignity of the human person,  </text>
<text top="521" left="142" width="38" height="9" font="6"><i>Recalling</i></text>
<text top="521" left="180" width="304" height="9" font="1"> Human Rights Council resolution 23/14 of 24 June 2013 and all relevant </text>
<text top="533" left="113" width="371" height="9" font="1">previous resolutions and decisions on the right of everyone to the enjoyment of the highest </text>
<text top="545" left="113" width="371" height="9" font="1">attainable  standard  of  physical  and  mental  health  adopted  by  the  Council,  the  General </text>
<text top="557" left="113" width="205" height="9" font="1">Assembly and the Commission on Human Rights,  </text>
<text top="575" left="142" width="60" height="9" font="6"><i>Recalling  also</i></text>
<text top="575" left="202" width="282" height="9" font="1">  the  Declaration  on  the  Right  to  Development,  which,  inter  alia, </text>
<text top="587" left="113" width="371" height="9" font="1">establishes  that  States  should  take,  at  the  national  level,  all  measures  necessary  for  the </text>
<text top="599" left="113" width="371" height="9" font="1">realization of the right to development and should ensure, inter alia, equality of opportunity </text>
<text top="611" left="113" width="260" height="9" font="1">for all in their access to basic resources, such as health services,  </text>
<text top="629" left="142" width="50" height="9" font="6"><i>Reaffirming </i></text>
<text top="629" left="195" width="289" height="9" font="1">General  Assembly  resolution  70/1  of  27  September  2015,  entitled </text>
<text top="639" left="113" width="371" height="11" font="1">“Transforming  our  world:  the  2030  Agenda  for  Sustainable  Development”,  in  which  the </text>
<text top="653" left="113" width="371" height="9" font="1">Assembly adopted the outcome document of the United Nations summit for the adoption of </text>
<text top="665" left="113" width="371" height="9" font="1">the post-2015 development agenda, recognizing that eradicating poverty in all its forms and </text>
<text top="677" left="113" width="371" height="9" font="1">dimensions,  including  extreme  poverty,  is  the  greatest  global  challenge  and  an </text>
<text top="689" left="113" width="371" height="9" font="1">indispensable  requirement  for  sustainable  development,  and  envisaging  a  world  free  of </text>
<text top="701" left="113" width="371" height="9" font="1">poverty, hunger, disease and want, a world of universal respect for human rights and human </text>
<text top="29" left="57" width="0" height="1" font="7"> </text>
<text top="50" left="57" width="2" height="9" font="1"> </text>
<text top="55" left="120" width="89" height="13" font="8">United Nations </text>
<text top="53" left="454" width="14" height="18" font="9">A</text>
<text top="60" left="469" width="72" height="9" font="1">/HRC/RES/32/15 </text>
<text top="118" left="117" width="2" height="9" font="1"> </text>
<text top="81" left="120" width="161" height="18" font="10"><b>General Assembly </b></text>
<text top="108" left="120" width="5" height="18" font="10"><b> </b></text>
<text top="87" left="392" width="62" height="9" font="1">Distr.: General </text>
<text top="99" left="392" width="54" height="9" font="1">18 July 2016 </text>
<text top="111" left="392" width="2" height="9" font="1"> </text>
<text top="123" left="392" width="72" height="9" font="1">Original: English </text>
</page>
<page number="2" position="absolute" top="0" left="0" height="842" width="595">
	<fontspec id="11" size="9" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="12" size="9" family="Times New Roman" color="#000000"/>
	<fontspec id="13" size="6" family="Times New Roman" color="#000000"/>
<text top="59" left="57" width="74" height="8" font="11"><b>A/HRC/RES/32/15 </b></text>
<text top="764" left="57" width="5" height="8" font="11"><b>2</b></text>
<text top="764" left="61" width="2" height="8" font="12"> </text>
<text top="764" left="539" width="2" height="7" font="0"> </text>
<text top="88" left="113" width="371" height="9" font="1">dignity that includes equitable and universal access to health care and social protection, and </text>
<text top="100" left="113" width="233" height="9" font="1">where physical, mental and social well-being are assured, </text>
<text top="118" left="142" width="47" height="9" font="6"><i>Welcoming </i></text>
<text top="118" left="191" width="293" height="9" font="1">the  Sustainable  Development  Goals,  including,  inter  alia,  Goal  3  on </text>
<text top="130" left="113" width="371" height="9" font="1">ensuring  healthy  lives  and  promoting  well-being  for  all  at  all  ages,  and  its  specific  and </text>
<text top="142" left="113" width="252" height="9" font="1">interlinked targets, and other health-related Goals and targets,  </text>
<text top="160" left="142" width="122" height="9" font="6"><i>Taking note with appreciation</i></text>
<text top="160" left="263" width="221" height="9" font="1"> of the report of the Chairman-Rapporteur of the 2015 </text>
<text top="172" left="113" width="56" height="9" font="1">Social Forum,</text>
<text top="171" left="170" width="3" height="5" font="13">1</text>
<text top="172" left="173" width="187" height="9" font="1"> held in Geneva from 18 to 20 February 2015, </text>
<text top="172" left="359" width="2" height="9" font="4"><b> </b></text>
<text top="190" left="142" width="102" height="9" font="6"><i>Noting  with appreciation</i></text>
<text top="190" left="244" width="240" height="9" font="1"> the Human Rights Council panel  convened to discuss the </text>
<text top="202" left="113" width="371" height="9" font="1">progress in and challenges of addressing human rights issues in the context of efforts to end </text>
<text top="214" left="113" width="216" height="9" font="1">the HIV/AIDS epidemic by 2030, on 11 March 2016, </text>
<text top="232" left="142" width="122" height="9" font="6"><i>Noting with appreciation also</i></text>
<text top="232" left="264" width="218" height="9" font="1"> the Secretary-General’s decision to establish a High-</text>
<text top="244" left="113" width="371" height="9" font="1">level Panel on Access to Medicines, with the mandate to make proposals on how to address </text>
<text top="256" left="113" width="371" height="9" font="1">policy  incoherence  in  public  health,  trade,  the  justifiable  rights  of  inventors,  and  human </text>
<text top="268" left="113" width="371" height="9" font="1">rights,  and  recognizing  the  participation  of  the  Office  of  the  United  Nations  High </text>
<text top="280" left="113" width="338" height="9" font="1">Commissioner for Human Rights in the expert advisory group supporting the Panel, </text>
<text top="298" left="142" width="86" height="9" font="6"><i>Noting with concern </i></text>
<text top="298" left="229" width="256" height="9" font="1">that,  for millions of people throughout the  world, the  full  and </text>
<text top="310" left="113" width="371" height="9" font="1">equal enjoyment of the right to the highest attainable standard of physical and mental health </text>
<text top="322" left="113" width="95" height="9" font="1">remains a distant goal,  </text>
<text top="340" left="142" width="46" height="9" font="6"><i>Concerned </i></text>
<text top="340" left="190" width="294" height="9" font="1">about  the  interrelatedness  between  poverty  and  the  realization  of  the </text>
<text top="352" left="113" width="371" height="9" font="1">right of everyone to the enjoyment of the highest attainable standard of physical and mental </text>
<text top="364" left="113" width="371" height="9" font="1">health,  in  particular  the  fact  that  ill  health  can  be  both  a  cause  and  a  consequence  of </text>
<text top="376" left="113" width="38" height="9" font="1">poverty,  </text>
<text top="394" left="142" width="52" height="9" font="6"><i>Recognizing </i></text>
<text top="394" left="197" width="288" height="9" font="1">that  universal  health  coverage  implies  that  all  people  have  access </text>
<text top="406" left="113" width="371" height="9" font="1">without  discrimination  to  nationally  determined  sets  of  the  needed  promotive,  preventive, </text>
<text top="418" left="113" width="371" height="9" font="1">curative,  palliative  and  rehabilitative  essential  health  services,  and  essential,  safe, </text>
<text top="430" left="113" width="371" height="9" font="1">affordable,  efficacious  and  quality  medicines  and  vaccines,  while  ensuring  that  the  use  of </text>
<text top="442" left="113" width="371" height="9" font="1">these  services does not expose users to financial  hardship,  with a  special emphasis on the </text>
<text top="454" left="113" width="255" height="9" font="1">poor, vulnerable and marginalized segments of the population,  </text>
<text top="472" left="142" width="49" height="9" font="6"><i>Recognizing</i></text>
<text top="472" left="191" width="2" height="9" font="4"><b> </b></text>
<text top="472" left="194" width="17" height="9" font="6"><i>also</i></text>
<text top="472" left="211" width="273" height="9" font="1"> the need for States, in cooperation with international organizations </text>
<text top="484" left="113" width="371" height="9" font="1">and  civil  society,  including  non-governmental  organizations  and  the  private  sector, </text>
<text top="496" left="113" width="371" height="9" font="1">including  pharmaceutical  companies,  to  create  favourable  conditions  at  the  national, </text>
<text top="508" left="113" width="371" height="9" font="1">regional  and  international  levels  to  ensure  the  full  and  effective  enjoyment  of  the  right  of </text>
<text top="520" left="113" width="299" height="9" font="1">everyone to the highest attainable standard of physical and mental health,  </text>
<text top="538" left="142" width="41" height="9" font="6"><i>Recalling </i></text>
<text top="538" left="183" width="301" height="9" font="1">that the Doha Ministerial Declaration on the Agreement on Trade-Related </text>
<text top="550" left="113" width="371" height="9" font="1">Aspects of Intellectual Property Rights and Public Health confirms that the Agreement does </text>
<text top="562" left="113" width="371" height="9" font="1">not  and  should  not  prevent  members  of  the  World  Trade  Organization  from  taking </text>
<text top="574" left="113" width="371" height="9" font="1">measures  to  protect  public  health,  and  that  the  Declaration,  accordingly,  while  reiterating </text>
<text top="586" left="113" width="371" height="9" font="1">the  commitment  to  the  Agreement,  affirms  that  it  can  and  should  be  interpreted  and </text>
<text top="598" left="113" width="371" height="9" font="1">implemented in a manner supportive of the rights of members of the Organization to protect </text>
<text top="610" left="113" width="371" height="9" font="1">public  health  and,  in  particular,  to  promote  access  to  medicines  for  all,  and  further </text>
<text top="622" left="113" width="371" height="9" font="1">recognizes, in this connection, the right of members of the Organization to use, to the full, </text>
<text top="634" left="113" width="371" height="9" font="1">the  provisions  of  the  above-mentioned  Agreement,  which  provide  flexibility  for  this </text>
<text top="646" left="113" width="37" height="9" font="1">purpose, </text>
<text top="664" left="142" width="45" height="9" font="6"><i>Regretting </i></text>
<text top="664" left="190" width="294" height="9" font="1">the  high  number  of  people  still  without  access  to  affordable,  safe, </text>
<text top="676" left="113" width="371" height="9" font="1">efficacious and quality medicines, and underscoring that improving such access could save </text>
<text top="693" left="91" width="2" height="9" font="1"> </text>
<text top="693" left="164" width="2" height="9" font="1"> </text>
<text top="708" left="57" width="2" height="8" font="12"> </text>
<text top="706" left="105" width="3" height="5" font="13">1</text>
<text top="708" left="108" width="61" height="8" font="12">   A/HRC/29/44. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="842" width="595">
<text top="59" left="467" width="74" height="8" font="11"><b>A/HRC/RES/32/15 </b></text>
<text top="764" left="57" width="2" height="7" font="0"> </text>
<text top="764" left="534" width="7" height="8" font="11"><b>3 </b></text>
<text top="88" left="113" width="371" height="9" font="1">millions  of  lives  every  year,  and  noting  with  deep  concern  that,  according  to  the  World </text>
<text top="100" left="113" width="371" height="9" font="1">Health Organization in its World Medicines Situations Report of 2011, at least one third of </text>
<text top="112" left="113" width="371" height="9" font="1">the world population has no regular access to medicines, while recognizing that the lack of </text>
<text top="124" left="113" width="371" height="9" font="1">access to medicines is a global challenge that affects people not only developing countries </text>
<text top="136" left="113" width="371" height="9" font="1">but also in developed countries,  even though the disease burden is disproportionately high </text>
<text top="148" left="113" width="99" height="9" font="1">in developing countries, </text>
<text top="166" left="142" width="46" height="9" font="6"><i>Concerned </i></text>
<text top="166" left="192" width="292" height="9" font="1">at  the  lack  of  access  to  quality,  safe,  efficacious  and  affordable </text>
<text top="178" left="113" width="371" height="9" font="1">medicines for children in appropriate dosage forms, and  at problems in the rational use of </text>
<text top="188" left="113" width="371" height="11" font="1">children’s medicines in many countries, and that, globally, children aged under five years </text>
<text top="202" left="113" width="371" height="9" font="1">still  do  not  have  secure  access  to  medicines  for  the  treatment  of  pneumonia,  tuberculosis, </text>
<text top="214" left="113" width="371" height="9" font="1">diarrheal  diseases,  HIV  infection  and  malaria,  or  medicines  for  many  other  infectious </text>
<text top="226" left="113" width="226" height="9" font="1">diseases, non-communicable diseases and rare diseases, </text>
<text top="244" left="142" width="67" height="9" font="6"><i>Concerned  also</i></text>
<text top="244" left="209" width="275" height="9" font="1">  that  the  increasing  incidence  of  non-communicable  diseases </text>
<text top="256" left="113" width="371" height="9" font="1">constitutes  a  heavy  burden  on  society,  with  serious  social  and  economic  consequences, </text>
<text top="268" left="113" width="371" height="9" font="1">which  represent  a  leading  threat  to  human  health  and  development,  and  recognizing  the </text>
<text top="280" left="113" width="371" height="9" font="1">urgent  need to improve accessibility to safe, affordable, efficacious and quality  medicines </text>
<text top="292" left="113" width="371" height="9" font="1">and  technologies  to  diagnose  and  treat  non-communicable  diseases,  to  strengthen  viable </text>
<text top="304" left="113" width="371" height="9" font="1">financing  options,  and  to  promote  the  use  of  affordable  medicines,  including  generics,  as </text>
<text top="316" left="113" width="371" height="9" font="1">well  as  improved  access  to  preventive,  curative,  palliative  and  rehabilitative  services, </text>
<text top="328" left="113" width="148" height="9" font="1">particularly at the community level,  </text>
<text top="346" left="142" width="104" height="9" font="6"><i>Expressing  deep  concern</i></text>
<text top="346" left="246" width="238" height="9" font="1">  at  recent  outbreaks  of  highly  infectious  pathogens  with </text>
<text top="358" left="113" width="371" height="9" font="1">epidemic  potential,  which  demonstrate  the  potential  vulnerability  of  populations  to  them, </text>
<text top="370" left="113" width="371" height="9" font="1">and in this context reaffirming and underscoring the importance of the development of new </text>
<text top="382" left="113" width="371" height="9" font="1">and  innovative  medicines  and  vaccines  and  of  ensuring  access  to  safe,  affordable, </text>
<text top="394" left="113" width="371" height="9" font="1">efficacious  and  quality  medicines  and  vaccines  to  all,  as  well  as  strengthening  health </text>
<text top="406" left="113" width="250" height="9" font="1">system capacities for preventing and responding to outbreaks, </text>
<text top="424" left="142" width="38" height="9" font="6"><i>Recalling</i></text>
<text top="424" left="180" width="304" height="9" font="1"> the Global Strategy and Plan of Action on Public Health, Innovation and </text>
<text top="436" left="113" width="371" height="9" font="1">Intellectual Property of the World Health Organization, and commending the efforts of the </text>
<text top="448" left="113" width="371" height="9" font="1">Organization  to  fill  gaps  in  health  research  and  development  for  the  relevant  needs  of </text>
<text top="460" left="113" width="371" height="9" font="1">developing countries, including neglected diseases and potential areas where market failure </text>
<text top="472" left="113" width="371" height="9" font="1">exists,  through  the  follow-up  to  the  report  of  the  Consultative  Expert  Working  Group  on </text>
<text top="484" left="113" width="371" height="9" font="1">Research and Development, and reiterating that health research and development should be </text>
<text top="496" left="113" width="371" height="9" font="1">needs-driven, evidence-based, guided by the core principles of affordability, effectiveness, </text>
<text top="508" left="113" width="250" height="9" font="1">efficiency and equity, and considered a shared responsibility,  </text>
<text top="526" left="142" width="12" height="9" font="1">1.  </text>
<text top="526" left="170" width="45" height="9" font="6"><i>Recognizes</i></text>
<text top="526" left="215" width="269" height="9" font="1">  that  access  to  medicines  is  one  of  the  fundamental  elements  in </text>
<text top="538" left="113" width="371" height="9" font="1">achieving progressively the full realization of the right of everyone to the enjoyment of the </text>
<text top="550" left="113" width="235" height="9" font="1">highest attainable standard of physical and mental health;  </text>
<text top="568" left="142" width="8" height="9" font="1">2.</text>
<text top="568" left="149" width="5" height="9" font="6"><i>  </i></text>
<text top="568" left="170" width="32" height="9" font="6"><i>Stresses</i></text>
<text top="568" left="202" width="282" height="9" font="1">  the  responsibility  of  States  to  ensure  access  for  all,  without </text>
<text top="580" left="113" width="371" height="9" font="1">discrimination,  to  medicines,  in  particular  essential  medicines,  that  are  affordable,  safe, </text>
<text top="592" left="113" width="110" height="9" font="1">efficacious and of quality;  </text>
<text top="610" left="142" width="12" height="9" font="1">3.  </text>
<text top="610" left="170" width="45" height="9" font="6"><i>Calls  upon</i></text>
<text top="610" left="215" width="269" height="9" font="1">  States  to  promote  access  to  medicines  for  all,  including  through </text>
<text top="622" left="113" width="371" height="9" font="1">the  use,  to  the  full,  of  the  provisions  of  the  Agreement  on  Trade-Related  Aspects  of </text>
<text top="634" left="113" width="371" height="9" font="1">Intellectual Property Rights, which provide flexibility for that purpose, recognizing that the </text>
<text top="646" left="113" width="371" height="9" font="1">protection  of  intellectual  property  is  important  for  the  development  of  new  medicines,  as </text>
<text top="658" left="113" width="193" height="9" font="1">well as the concerns about its effects on prices;  </text>
<text top="676" left="142" width="8" height="9" font="1">4.</text>
<text top="676" left="149" width="2" height="9" font="4"><b> </b></text>
<text top="676" left="170" width="67" height="9" font="6"><i>Also  calls  upon</i></text>
<text top="676" left="237" width="247" height="9" font="1">  States  to  take  steps  to  implement  policies  and  plans  to </text>
<text top="688" left="113" width="371" height="9" font="1">promote access to comprehensive and cost-effective prevention, treatment and care for the </text>
<text top="700" left="113" width="371" height="9" font="1">integrated  management  of  non-communicable  diseases,  including,  inter  alia,  increased </text>
<text top="712" left="113" width="371" height="9" font="1">access  to  affordable,  safe,  efficacious  and  quality  medicines  and  diagnostics  and  other </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="842" width="595">
<text top="59" left="57" width="74" height="8" font="11"><b>A/HRC/RES/32/15 </b></text>
<text top="764" left="57" width="5" height="8" font="11"><b>4</b></text>
<text top="764" left="61" width="2" height="8" font="12"> </text>
<text top="764" left="539" width="2" height="7" font="0"> </text>
<text top="88" left="113" width="371" height="9" font="1">technologies,  including  through  the  full  use  of  Trade-Related  Aspects  of  Intellectual </text>
<text top="100" left="113" width="116" height="9" font="1">Property Rights flexibilities; </text>
<text top="118" left="142" width="10" height="9" font="1">5. </text>
<text top="118" left="170" width="43" height="9" font="6"><i>Reiterates </i></text>
<text top="118" left="214" width="270" height="9" font="1">the call  upon  States to continue  to collaborate, as appropriate, on </text>
<text top="130" left="113" width="371" height="9" font="1">models  and  approaches  that  support  the  delinkage  of  the  cost  of  new  research  and </text>
<text top="142" left="113" width="371" height="9" font="1">development  from  the  prices  of  medicines,  vaccines  and  diagnostics  for  diseases  that </text>
<text top="154" left="113" width="371" height="9" font="1">predominantly  affect  developing  countries,  including  emerging  and  neglected  tropical </text>
<text top="166" left="113" width="371" height="9" font="1">diseases,  so  as  to  ensure  their  sustained  accessibility,  affordability  and  availability  and  to </text>
<text top="178" left="113" width="189" height="9" font="1">ensure access to treatment for all those in need;</text>
<text top="178" left="303" width="5" height="9" font="4"><b>  </b></text>
<text top="196" left="142" width="10" height="9" font="1">6. </text>
<text top="196" left="170" width="46" height="9" font="6"><i>Calls  upon</i></text>
<text top="196" left="216" width="268" height="9" font="1">  the  international  community  to  continue  to  assist  developing </text>
<text top="208" left="113" width="371" height="9" font="1">countries in promoting the full realization of the right of everyone to the enjoyment of the </text>
<text top="220" left="113" width="371" height="9" font="1">highest  attainable  standard  of  physical  and  mental  health,  including  through  access  to </text>
<text top="232" left="113" width="371" height="9" font="1">medicines  that  are  affordable,  safe,  efficacious  and  of  quality,  and  through  financial  and </text>
<text top="244" left="113" width="371" height="9" font="1">technical  support  and  training  of  personnel,  while  recognizing  that  the  primary </text>
<text top="256" left="113" width="316" height="9" font="1">responsibility for promoting and protecting all human rights rests with States;  </text>
<text top="274" left="142" width="10" height="9" font="1">7. </text>
<text top="274" left="170" width="47" height="9" font="6"><i>Recognizes </i></text>
<text top="274" left="222" width="262" height="9" font="1">the  innovative  funding  mechanisms  that  contribute  to  the </text>
<text top="286" left="113" width="371" height="9" font="1">availability of vaccines and medicines in developing countries, such as the Global Fund to </text>
<text top="298" left="113" width="371" height="9" font="1">Fight AIDS, Tuberculosis and Malaria, the Gavi Alliance and UNITAID, and calls upon all </text>
<text top="310" left="113" width="371" height="9" font="1">States,  United  Nations  agencies,  funds  and  programmes,  in  particular  the  World  Health </text>
<text top="322" left="113" width="371" height="9" font="1">Organization,  and  relevant  intergovernmental  organizations,  within  their  respective </text>
<text top="334" left="113" width="371" height="9" font="1">mandates,  and  encourages  relevant  stakeholders,  including  pharmaceutical  companies, </text>
<text top="346" left="113" width="371" height="9" font="1">while  safeguarding  public  health  from  undue  influence  by  any  form  of  real,  perceived  or </text>
<text top="358" left="113" width="371" height="9" font="1">potential conflict of interest, to further collaborate to enable equitable access to quality, safe </text>
<text top="370" left="113" width="371" height="9" font="1">and  efficacious  medicines  that  are  affordable  to  all,  including  those  living  in  poverty, </text>
<text top="382" left="113" width="207" height="9" font="1">children and other persons in vulnerable situations; </text>
<text top="400" left="142" width="10" height="9" font="1">8. </text>
<text top="400" left="170" width="27" height="9" font="6"><i>Urges </i></text>
<text top="400" left="200" width="284" height="9" font="1">all  States,  United  Nations  agencies  and  programmes  and  relevant </text>
<text top="412" left="113" width="371" height="9" font="1">intergovernmental  organizations,  especially  the  World  Health  Organization,  within  their </text>
<text top="424" left="113" width="371" height="9" font="1">respective  mandates,  and  encourages  non-governmental  organizations  and  relevant </text>
<text top="436" left="113" width="371" height="9" font="1">stakeholders,  including  pharmaceutical  companies,  to  promote  innovative  research  and </text>
<text top="448" left="113" width="371" height="9" font="1">development  to  address  health  needs  in  developing  countries,  including  access  to  quality, </text>
<text top="460" left="113" width="371" height="9" font="1">safe,  efficacious  and  affordable  medicines,  and  in  particular  with  regard  to  diseases </text>
<text top="472" left="113" width="371" height="9" font="1">disproportionately  affecting  developing  countries,  and  the  challenges  arising  from  the </text>
<text top="484" left="113" width="371" height="9" font="1">growing burden of non-communicable diseases, taking into account the Global Strategy and </text>
<text top="496" left="113" width="371" height="9" font="1">Plan of Action on Public Health, Innovation and Intellectual Property of the World Health </text>
<text top="508" left="113" width="60" height="9" font="1">Organization;  </text>
<text top="526" left="142" width="5" height="9" font="1">9</text>
<text top="526" left="147" width="5" height="9" font="6"><i>. </i></text>
<text top="526" left="170" width="29" height="9" font="6"><i>Invites </i></text>
<text top="526" left="200" width="12" height="9" font="1">the</text>
<text top="526" left="212" width="2" height="9" font="6"><i> </i></text>
<text top="526" left="216" width="268" height="9" font="1">Special  Rapporteur  on  the  right  of  everyone  to  the  enjoyment  of </text>
<text top="538" left="113" width="371" height="9" font="1">the  highest  attainable  standard  of  physical  and  mental  health,  while  considering  the  many </text>
<text top="550" left="113" width="371" height="9" font="1">ways  towards  the  full  realization  of  the  right  of  everyone  to  the  enjoyment  of  the  highest </text>
<text top="562" left="113" width="371" height="9" font="1">attainable standard of physical and mental health, to continue to focus on the human rights </text>
<text top="574" left="113" width="371" height="9" font="1">dimension  of  access  to  medicines  when  discharging  his  or  her  duties,  in  accordance  with </text>
<text top="586" left="113" width="56" height="9" font="1">the mandate;  </text>
<text top="604" left="142" width="15" height="9" font="1">10. </text>
<text top="604" left="170" width="29" height="9" font="6"><i>Invites </i></text>
<text top="604" left="203" width="281" height="9" font="1">Member  States  and  all  stakeholders,  including  relevant  United </text>
<text top="616" left="113" width="371" height="9" font="1">Nations bodies, agencies, funds and programmes, treaty bodies, special procedure mandate </text>
<text top="628" left="113" width="371" height="9" font="1">holders, national human rights institutions, civil society and the private sector, to promote </text>
<text top="640" left="113" width="371" height="9" font="1">policy coherence in the areas of human rights, intellectual property and international trade </text>
<text top="652" left="113" width="223" height="9" font="1">and investment when considering access to medicines;  </text>
<text top="670" left="142" width="15" height="9" font="1">11. </text>
<text top="670" left="170" width="35" height="9" font="6"><i>Decides </i></text>
<text top="670" left="209" width="276" height="9" font="1">to  convene,  at  its  thirty-fourth  session,  a  panel  discussion  to </text>
<text top="682" left="113" width="371" height="9" font="1">exchange  views  on  good  practices  and  key  challenges  relevant  to  access  to  medicines  as </text>
<text top="694" left="113" width="371" height="9" font="1">one  of  the  fundamental  elements  of  the  right  of  everyone  to  the  enjoyment  of  the  highest </text>
<text top="706" left="113" width="371" height="9" font="1">attainable  standard  of  physical  and  mental  health,  taking  into  account  all  relevant  reports, </text>
<text top="718" left="113" width="303" height="9" font="1">and that the discussion shall be fully accessible to persons with disabilities, </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="842" width="595">
<text top="59" left="467" width="74" height="8" font="11"><b>A/HRC/RES/32/15 </b></text>
<text top="764" left="57" width="2" height="7" font="0"> </text>
<text top="764" left="534" width="7" height="8" font="11"><b>5 </b></text>
<text top="88" left="142" width="15" height="9" font="1">12. </text>
<text top="88" left="170" width="27" height="9" font="6"><i>Invites</i></text>
<text top="88" left="197" width="288" height="9" font="1">  the  United  Nations  High  Commissioner  for  Human  Rights  to  liaise </text>
<text top="100" left="113" width="371" height="9" font="1">with States and all stakeholders, including relevant United Nations bodies, agencies, funds </text>
<text top="112" left="113" width="371" height="9" font="1">and  programmes,  treaty  bodies,  special  procedure  mandate  holders,  national  human  rights </text>
<text top="124" left="113" width="371" height="9" font="1">institutions  and  civil  society,  with  a  view  to  ensuring  their  participation  in  the  panel </text>
<text top="136" left="113" width="49" height="9" font="1">discussion;  </text>
<text top="154" left="142" width="15" height="9" font="1">13. </text>
<text top="154" left="170" width="38" height="9" font="6"><i>Requests </i></text>
<text top="154" left="209" width="275" height="9" font="1">the  High  Commissioner  to  prepare  a  summary  report  on  the  panel </text>
<text top="166" left="113" width="315" height="9" font="1">discussion to submit it to the Human Rights Council at its thirty-sixth session. </text>
<text top="183" left="429" width="53" height="9" font="6"><i>43rd meeting</i></text>
<text top="183" left="482" width="2" height="9" font="1"> </text>
<text top="195" left="435" width="47" height="9" font="6"><i>1 July 2016</i></text>
<text top="195" left="482" width="2" height="9" font="1"> </text>
<text top="207" left="113" width="106" height="9" font="1">[Adopted without a vote.] </text>
<text top="231" left="255" width="2" height="9" font="1"> </text>
<text top="231" left="283" width="2" height="9" font="1"> </text>
<text top="231" left="312" width="2" height="9" font="1"> </text>
<text top="231" left="340" width="2" height="9" font="1"> </text>
</page>
</pdf2xml>
